Susquehanna International Group
GMVD

Susquehanna International Group’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Susquehanna International Group’s Portfolio GMVD Stock Details GMVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-369
Closed -$3K – 14199
2022
Q3 		$3K Buy
+369
New +$5.42K ﹤0.01% 12934

Other funds holding GMVD

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Susquehanna International Group's GMVD Position: Q4 2022 in Review

Susquehanna International Group sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q4 2022, closing a stake of 369 shares — an estimated $3K sold.

Susquehanna International Group first reported a position in GMVD in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 6 funds tracked by Wall St. Rank hold GMVD as of Q4 2022.

  • Susquehanna International Group reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 369 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q4 2022, an estimated $3K.
  • Susquehanna International Group first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q3 2022 and held it in 1 quarter.
  • Susquehanna International Group's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $3K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.